
UroGen Pharma Ltd
URGNHealthcare|Biotechnology|USA
$38.57
-1.67 (-4.15%)
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (80)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Schoenberg Mark | Chief Medical Officer | 2026-07-09 | SELL | 10,000 | $40 | $400K |
| Schoenberg Mark | Chief Medical Officer | 2026-06-22 | SELL | 10,000 | $35.01 | $350.1K |
| Schoenberg Mark | Chief Medical Officer | 2026-06-08 | SELL | 5,222 | $27.3 | $142.6K |
| Schoenberg Mark | Chief Medical Officer | 2026-05-08 | SELL | 10,000 | $30 | $300K |
| Smith Jason Drew | General Counsel | 2026-02-03 | SELL | 7,479 | $19.69 | $147.3K |
| Schoenberg Mark | Chief Medical Officer | 2026-02-03 | SELL | 7,373 | $19.69 | $145.2K |
| Schoenberg Mark | Chief Medical Officer | 2025-11-19 | SELL | 10,000 | $25 | $250K |
| Degnan Chris | CFO | 2025-10-08 | SELL | 2,203 | $16.85 | $37.1K |
| Schoenberg Mark | Chief Medical Officer | 2025-09-08 | SELL | 871 | $19.11 | $16.6K |
| Smith Jason Drew | General Counsel | 2025-09-08 | SELL | 1,520 | $19.11 | $29K |
| Schoenberg Mark | Chief Medical Officer | 2025-08-11 | SELL | 10,000 | $17.69 | $176.9K |
| Schoenberg Mark | Chief Medical Officer | 2025-07-28 | SELL | 5,149 | $19.14 | $98.6K |
| Smith Jason Drew | General Counsel | 2025-07-28 | SELL | 7,522 | $19.14 | $144K |
| Schoenberg Mark | Chief Medical Officer | 2025-06-09 | SELL | 5,162 | $7.37 | $38K |
| Schoenberg Mark | Chief Medical Officer | 2025-01-31 | SELL | 4,551 | $11.14 | $50.7K |
| Smith Jason Drew | General Counsel | 2025-01-31 | SELL | 7,379 | $11.14 | $82.2K |
| Schoenberg Mark | Chief Medical Officer | 2024-09-09 | SELL | 859 | $13.08 | $11.2K |
| Smith Jason Drew | General Counsel | 2024-09-09 | SELL | 1,521 | $13.08 | $19.9K |
| Schoenberg Mark | Chief Medical Officer | 2024-06-10 | SELL | 5,153 | $13.08 | $67.4K |
| Schoenberg Mark | Chief Medical Officer | 2024-03-18 | SELL | 12,000 | $14.05 | $168.6K |
| Smith Jason Drew | General Counsel | 2024-02-01 | SELL | 4,993 | $15.78 | $78.8K |
| Schoenberg Mark | Chief Medical Officer | 2024-02-01 | SELL | 3,789 | $15.78 | $59.8K |
| Smith Jason Drew | General Counsel | 2024-01-31 | SELL | 4,993 | $15.74 | $78.6K |
| Schoenberg Mark | Chief Medical Officer | 2024-01-31 | SELL | 3,789 | $15.74 | $59.6K |
| Smith Jason Drew | General Counsel | 2023-08-31 | SELL | 3,800 | $18.01 | $68.4K |
| Smith Jason Drew | General Counsel | 2023-01-31 | SELL | 1,636 | $10.12 | $16.6K |
| Schoenberg Mark | Chief Medical Officer | 2023-01-31 | SELL | 1,900 | $10.12 | $19.2K |
| Schoenberg Mark | Chief Medical Officer | 2022-10-31 | SELL | 258 | $11.85 | $3.1K |
| Smith Jason Drew | General Counsel | 2022-08-31 | SELL | 3,606 | $7.21 | $26K |
| Schoenberg Mark | Chief Medical Officer | 2022-08-01 | SELL | 259 | $7.81 | $2K |
| Schoenberg Mark | Chief Medical Officer | 2022-04-30 | SELL | 254 | $6.62 | $1.7K |
| Smith Jason Drew | General Counsel | 2022-01-31 | SELL | 414 | $7.58 | $3.1K |
| Henderson Molly | CFO | 2022-01-31 | SELL | 331 | $7.58 | $2.5K |
| Schoenberg Mark | Chief Medical Officer | 2022-01-31 | SELL | 1,374 | $7.58 | $10.4K |
| Barrett Elizabeth A. | CEO | 2022-01-31 | SELL | 8,195 | $7.58 | $62.1K |
| Schoenberg Mark | Chief Medical Officer | 2022-01-26 | SELL | 111 | $8.09 | $0.9K |
| Barrett Elizabeth A. | CEO | 2022-01-04 | SELL | 46,968 | $9.15 | $429.8K |
| Smith Jason Drew | General Counsel | 2021-11-30 | SELL | 3,803 | $12.03 | $45.8K |
| Henderson Molly | CFO | 2021-11-30 | SELL | 2,587 | $12.03 | $31.1K |
| Schoenberg Mark | Chief Medical Officer | 2021-11-18 | BUY | 160 | $13.1 | $2.1K |
| Schoenberg Mark | Chief Medical Officer | 2021-11-01 | SELL | 258 | $17.16 | $4.4K |
| Schoenberg Mark | Chief Medical Officer | 2021-10-27 | SELL | 107 | $16.32 | $1.7K |
| Schoenberg Mark | Chief Medical Officer | 2021-08-02 | SELL | 243 | $15.64 | $3.8K |
| Schoenberg Mark | Chief Medical Officer | 2021-07-26 | SELL | 103 | $15.3 | $1.6K |
| Henderson Molly | CFO | 2021-05-17 | BUY | 2,500 | $15.85 | $39.6K |
| Smith Jason Drew | General Counsel | 2021-05-17 | BUY | 2,500 | $15.71 | $39.3K |
| Schoenberg Mark | Chief Medical Officer | 2021-01-31 | SELL | 1,076 | $22.07 | $23.7K |
| Schoenberg Mark | Chief Medical Officer | 2021-01-26 | SELL | 100 | $22.12 | $2.2K |
| Barrett Elizabeth A. | CEO | 2020-12-14 | BUY | 10,000 | $18.5 | $185K |
| Schoenberg Mark | Chief Medical Officer | 2020-12-04 | SELL | 662 | $19.85 | $13.1K |
| Schoenberg Mark | Chief Medical Officer | 2020-10-26 | SELL | 101 | $20.95 | $2.1K |
| PFREUNDSCHUH PETER P. | CFO | 2020-10-15 | SELL | 2,400 | $21.77 | $52.2K |
| Schoenberg Mark | Chief Medical Officer | 2020-09-04 | SELL | 348 | $20.2 | $7K |
| PFREUNDSCHUH PETER P. | CFO | 2020-09-01 | SELL | 509 | $22.82 | $11.6K |
| PFREUNDSCHUH PETER P. | CFO | 2020-07-27 | SELL | 141 | $23.51 | $3.3K |
| Schoenberg Mark | Chief Medical Officer | 2020-07-27 | SELL | 70 | $23.51 | $1.6K |
| Schoenberg Mark | Chief Medical Officer | 2020-06-04 | SELL | 349 | $27.51 | $9.6K |
| PFREUNDSCHUH PETER P. | CFO | 2020-05-20 | SELL | 358 | $25.07 | $9K |
| Schoenberg Mark | Chief Medical Officer | 2020-04-27 | SELL | 70 | $24.35 | $1.7K |
| PFREUNDSCHUH PETER P. | CFO | 2020-04-27 | SELL | 141 | $24.35 | $3.4K |
| Mullennix Stephen | COO | 2020-04-27 | SELL | 145 | $24.35 | $3.5K |
| PFREUNDSCHUH PETER P. | CFO | 2020-02-20 | SELL | 360 | $29.68 | $10.7K |
| Mullennix Stephen | COO | 2020-02-14 | SELL | 612 | $28.04 | $17.2K |
| PFREUNDSCHUH PETER P. | CFO | 2020-01-27 | SELL | 667 | $29.28 | $19.5K |
| Mullennix Stephen | COO | 2020-01-27 | SELL | 684 | $29.26 | $20K |
| Schoenberg Mark | Chief Medical Officer | 2020-01-27 | SELL | 322 | $29.15 | $9.4K |
| Barrett Elizabeth A. | CEO | 2019-11-21 | BUY | 7,530 | $28 | $210.8K |
| Barrett Elizabeth A. | CEO | 2019-11-20 | BUY | 7,470 | $28 | $209.2K |
| PFREUNDSCHUH PETER P. | CFO | 2019-11-20 | SELL | 354 | $28.41 | $10.1K |
| Schoenberg Mark | Chief Medical Officer | 2019-11-19 | BUY | 1,960 | $28.17 | $55.2K |
| Barrett Elizabeth A. | CEO | 2019-11-15 | BUY | 1,548 | $26 | $40.2K |
| Mullennix Stephen | COO | 2019-11-14 | SELL | 608 | $26 | $15.8K |
| Schoenberg Mark | Chief Medical Officer | 2019-09-04 | SELL | 343 | $33.92 | $11.6K |
| PFREUNDSCHUH PETER P. | CFO | 2019-08-20 | SELL | 1,416 | $33.07 | $46.8K |
| Mullennix Stephen | COO | 2019-08-15 | SELL | 608 | $31.65 | $19.2K |
| Mullennix Stephen | COO | 2019-05-14 | SELL | 608 | $37.98 | $23.1K |
| Schoenberg Mark | Chief Medical Officer | 2019-03-21 | BUY | 272 | $37.01 | $10.1K |
| Schoenberg Mark | Chief Medical Officer | 2019-03-06 | SELL | 1,991 | $37.3 | $74.3K |
| Mullennix Stephen | COO | 2019-02-14 | SELL | 2,804 | $37.3 | $104.6K |
| ProQuest Investments IV, L.P. | 10% Owner | 2017-11-28 | SELL | 209,298 | $40.6 | $8497.5K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked